Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.614 USD | +5.84% | +15.90% | +11.65% |
09/05 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.65% | 12Cr | |
+7.68% | 11TCr | |
+11.04% | 11TCr | |
+0.41% | 2.23TCr | |
-11.91% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.74% | 1.72TCr | |
+6.75% | 1.43TCr | |
+35.67% | 1.25TCr |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- HC Wainwright Adjusts Sangamo Therapeutics Price Target to $15 From $25, Maintains Buy Rating